Connect with us
On an international scale, one of the recent projects in which Ship2B Ventures has invested is Fosanis, a German company specializing in digital health. The Teutonic...
Between 2016 and 2021 the investment in the acquisition of medium and high-tech equipment in Aragonese healthcare has exceeded €43 million. Since that date, two linear...
Among the companies selected by Lanzadera there are projects related to the diagnosis of sepsis, pathologies related to muscles and skeletons or those that investigate skin...
The European Union plans to become an important point for clinical trials. The work plan is structured according to the ten ACT EU priority actions and...
The Swiss pharmaceutical company plans to lay off 8,000 workers worldwide, equivalent to 7.7% of the total workforce. The Novartis job cuts are part of the...
Bioasis Technologies Inc. has recently announced partnerships for its xB3 pharmaceutical platform with Janssen Biotech and Nueramedy, along with the acquisition of Cresence AS' Epidermal Growth...
During the project, two demonstration units will be built for the production of microalgae from these agricultural effluents, one in the Algarve and the second in...
At its latest meeting, held July 28th, REvalMed group has agreed to start work on the Therapeutic Positioning Reports (TPRs) for vutrisiran, voclosporin, tirzepatide, fosdenopterin, relatlimab...
The response to Covid-19 by governments and the medical community demonstrated the possibilities of rapid testing and vaccine development. Now one company, Alercell, is looking to...
As vaccine sales for Novavax, Moderna, and BioNTech shift in line with a changing Covid-19 situation, the results are being felt in the stock markets. Here...
 |
|
 |  |
 |
|